🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Drug Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are encouraged to message these accounts privately for supplier links, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a flourishing market exists on messaging services, where communities with numerous of participants share comparison photos, administration instructions and claims of rapid UK delivery. Sellers promote the drug there before directing customers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Professionals Voice Concerns

However, doctors and chemists have cautions that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.

Some professionals said the popularity for the experimental drug could be connected to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach pharmaceutical, advertising, and consumer laws, risking fines, legal action or prison.

Platform Reaction and Material Elimination

Based on the social media company, the platform has taken down problematic content and banned associated keywords and query recommendations. The organization stated it was dedicated to keeping the platform safe and investing in strengthening enforcement strategies.

Online Trading Activities

Research also found groups with up to 9,000 participants selling retatrutide using Telegram's integrated search feature, which functions like a online catalog. Typing “retatrutide” instantly displays channels with thousands of members, filled with images of slimming results, glowing testimonials and step-by-step guides for mixing or administering at residence.

Within minutes of entering one community, a seller posted WhatsApp details, where the majority of transactions take place. The seller sent an instruction manual and promised shipping within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about weight, health issues or past usage.

Item Information and Pricing

Within these communities, posts show dark colored parcels with Royal Mail labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors typically priced at £160 for 20mg. When asked how much time a pen should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A representative for Telegram said it regularly moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they cannot confirm. Although the science behind retatrutide is sound, these digital products may not include what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of an online medical service linked the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.

Her staff has already encountered patients injured by personal administration from unverified sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject users to possibly significant health risks”.